Thu, Jul 24, 2014, 9:15 AM EDT - U.S. Markets open in 15 mins.

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

  • secondopinion999 secondopinion999 Oct 30, 2013 8:56 AM Flag

    American College of Cardiology/American Heart Association

    The ACC has 43,000 members with a goal of leading the way to optimal CV care. And joint with the AHA, issue guidelines for heart attack/stroke prevention. This seems a powerful body to ask for intervention in resolving this FDA position. Surely, Omega supplements and cold water oily fish, certain nuts and veggies have long been recommended as providing CV benefit.

    And here we have a powerful offering in V that is summarily rejected as likely having no or only little benefit, but no safety concern. Something is wrong, terribly wrong. Did they just overturn this entire issue and suggest that no one with Tg's less than 500 should take EPA or generic fish oil supplements?? I am totally confused, but will continue to take my Omega pill and hope that V will be available for lower Tg population very soon.

    But bottom line to me is that the ACC/AHA should take a position and announce it to the world to clear the air, for the fishing industry, the supplement industry, and most importantly, for those in the population that are interested in CV prevention.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • kkllfla@bellsouth.net kkllfla Oct 30, 2013 9:19 AM Flag

      The FDA just told the ACC/AHA that their treatment protocol is all wrong for Trigs and CVD. There has been NO significant study results to reverse the manner in which Cardios treat this problem. The ACC/AHA should fire a volley at the FDA's recent statements. Has the ACC/AHA in their journals altered their position on how they treat this category of patients or cited any significant new studies ?

      Sentiment: Hold

    • kkllfla@bellsouth.net kkllfla Oct 30, 2013 9:14 AM Flag

      GREAT POINT....the FDA just told the ACC/AHA that they have been doing this all wrong. In 1 meeting the FDA just reversed a very proven and universally applied treatment protocol. How the hell did that happen ?
      And the real question is: Did the studies they cited, really prove a positive or negative relationship between the Trig levels and CVD ? NO, they just indicated a possible no provable effects from those rather small studies.

      Sentiment: Hold

 
AMRN
1.58+0.05(+3.16%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
General Motors Company
NYSEWed, Jul 23, 2014 4:01 PM EDT
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT